BRAIN Biotech AG

BATS-CHIXE:BNND Stock Report

Market Cap: €130.2m

BRAIN Biotech Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Aryan Moelker

Chief executive officer

€957.0k

Total compensation

CEO salary percentage43.9%
CEO tenure2.8yrs
CEO ownershipn/a
Management average tenure2.5yrs
Board average tenure3.8yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Aryan Moelker's remuneration changed compared to BRAIN Biotech's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2022n/an/a

-€8m

Mar 31 2022n/an/a

-€8m

Dec 31 2021n/an/a

-€4m

Sep 30 2021€957k€420k

-€5m

Jun 30 2021n/an/a

-€6m

Mar 31 2021n/an/a

-€6m

Dec 31 2020n/an/a

-€11m

Sep 30 2020€885k€280k

-€10m

Compensation vs Market: Aryan's total compensation ($USD1.01M) is above average for companies of similar size in the UK market ($USD348.41K).

Compensation vs Earnings: Aryan's compensation has increased whilst the company is unprofitable.

CEO

Aryan Moelker

2.8yrs

Tenure

€957,000

Compensation

Mr. Adriaan Moelker, also known as Aryan, serves as Director of SolasCure Limited. He has been Chairman of the Management Board and Chief Executive Officer of BRAIN Biotech AG (formerly known as B.R.A.I.N....

Leadership Team

NamePositionTenureCompensationOwnership
Adriaan Moelker
Chairman of the Management Board & CEO2.8yrs€957.00kno data
Ulrich Putsch
Co-Founderno datano datano data
Michael Schneiders
CFO & Member of Management Boardless than a yearno datano data
Ute Dechert
Vice President of Human Resources & Processes2.2yrsno datano data
Jurgen Eck
Consultant3yrs€392.00kno data
Martin Langer
Executive VP & Head of Business Developmentno datano datano data
Michael Krohn
Executive VP and Head of Research & Developmentno datano datano data
Thomas Deichmann
Head of Public Relationsno datano datano data
Michael Waidelich
Head of Skin Care Business Unit3.9yrsno datano data
Robbert Hoekstra
Head of Group Financeless than a yearno datano data
Paul Scholz
Technical Lead of Genome Editing Developmentno datano datano data

2.5yrs

Average Tenure

57yo

Average Age

Experienced Management: BNND's management team is considered experienced (2.5 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Georg Kellinghusen
Independent Chairman of the Supervisory Board5.8yrs€66.00kno data
Wiltrud Treffenfeldt
Member of Supervisory Board2.2yrs€28.00kno data
Stephen Catling
Member of Supervisory Board2.2yrs€31.00kno data
Michael Majerus
Independent Member of Supervisory Board3.8yrs€51.00kno data
Anna Eichhorn
Vice Chairwoman of the Supervisory Board5.8yrs€53.00kno data

3.8yrs

Average Tenure

61yo

Average Age

Experienced Board: BNND's board of directors are considered experienced (3.8 years average tenure).